Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
What Does Curative Intent Mean? A Survey of Oncology Clinicians at a Comprehensive Cancer Center
Kayley M. Ancy; Michael Tang; Allison de la Rosa; Jessica H. Brown; Linh Nguyen; Christopher M. Manuel; Eduardo Bruera; Christopher Flowers; Jeffrey Lee; David HuiShow moreShow less
1. Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; 2. Center for Goal Concordant Care Research, The University of Texas MD Anderson Cancer Center, Houston, TX; 3. Joan and Stanford Alexander Division of Geriatric and Palliative Medicine, Department of Internal Medicine, McGovern Medical School at UTHealth Houston, Houston, TX; 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; 5. Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; 6. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; 7. Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TXShow moreShow less
Comparative Cost-Effectiveness Analysis of First-Line Immunotherapy for Advanced Melanoma Based on 10-Year Clinical Outcomes
Guiyuan Xiang; Yin Sun; Xue Yang; Yao LiuShow moreShow less
1. Department of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China; 2. Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CAShow moreShow less
New Paradigms in the Management of Castleman Disease
Yoshito Nishimura; Thomas M. Habermann; Ariela NoyShow moreShow less
1. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN; 2. Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; 3. Weill Cornell Medical College, New York, NYShow moreShow less
Fostering Improvements in Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers
Ashley Orr; Taneal D. Carter; Mallory Stubblebine; Heather McKee Hurwitz; Tiffany Go; Leticia Mercado; Darryl Outlaw; Elizabeth Bouchard; Levent Dumenci; Crystal S. Denlinger; Alyssa A. SchatzShow moreShow less
1. National Comprehensive Cancer Network, Plymouth Meeting, PA; 2. Cleveland Clinic Cancer Institute, Cleveland, OH; 3. Fred Hutchinson Cancer Center, Seattle, WA; 4. Memorial Sloan Kettering Cancer Center, New York, NY; 5. The University of Alabama at Birmingham O’Neal Comprehensive Cancer Center, Birmingham, AL; 6. Roswell Park Comprehensive Cancer Center, Buffalo, NY; 7. Temple University College of Public Health, Philadelphia, PAShow moreShow less
County-Level Medical Debt and Its Associations With Cancer Stage and Survival in the United States
Xuesong Han; Nuo Nova Yang; Xin Hu; Qinjin Fan; Jingxuan Zhao; Zhiyuan Zheng; Kewei Sylvia Shi; Breno Braga; Changchuan Jiang; K. Robin YabroffShow moreShow less
1. Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, GA; 2. Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA; 3. Winship Cancer Institute, Emory University, Atlanta, GA; 4. Urban Institute, Washington, DC; 5. University of Texas Southwestern Medical Center, Dallas, TXShow moreShow less
Metabolic Tumor Volume as a Predictor of Benefit From Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer
Taejun Lee; Chang Gon Kim; Kyung Hwan Kim; Seoyoung Lee; Moonki Hong; Jae-Hoon Lee; Hyo Sup Shim; Sangwoo Kim; Su Kyoung Park; Min Hee Hong; Ja Hyun Yeo; Hong In Yoon; Arthur Cho; Hye Ryun KimShow moreShow less
1. Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea; 2. Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 4. Division of Medical Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea; 5. Department of Nuclear Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 6. Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea; 7. Department of Biomedical Systems Informatics and Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea; 8. Department of Medical Records, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 9. Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaShow moreShow less
FAQ
How long does Journal of the National Comprehensive Cancer Network take to review a manuscript?
As of 2026-11-19, CrushSCI has 12 complete review records for Journal of the National Comprehensive Cancer Network. The fastest paper went from submission to acceptance in 57 days (Fostering Improvements in Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers, received 2026-03-03, accepted 2026-04-29); the slowest took 245 days. The average is 138.6 days and the median is 137.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
